AU774288B2 - Bioactive, degradable composite for tissue engineering - Google Patents
Bioactive, degradable composite for tissue engineering Download PDFInfo
- Publication number
- AU774288B2 AU774288B2 AU32623/01A AU3262301A AU774288B2 AU 774288 B2 AU774288 B2 AU 774288B2 AU 32623/01 A AU32623/01 A AU 32623/01A AU 3262301 A AU3262301 A AU 3262301A AU 774288 B2 AU774288 B2 AU 774288B2
- Authority
- AU
- Australia
- Prior art keywords
- composite material
- bioactive
- degradable
- microspheres
- degradable composite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 77
- 230000000975 bioactive effect Effects 0.000 title claims abstract description 36
- 239000004005 microsphere Substances 0.000 claims abstract description 74
- 238000000034 method Methods 0.000 claims abstract description 27
- 238000012377 drug delivery Methods 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000005313 bioactive glass Substances 0.000 claims description 22
- 210000000988 bone and bone Anatomy 0.000 claims description 22
- 210000001519 tissue Anatomy 0.000 claims description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 17
- 229920000642 polymer Polymers 0.000 claims description 13
- 241001465754 Metazoa Species 0.000 claims description 9
- 239000001506 calcium phosphate Substances 0.000 claims description 7
- 235000011010 calcium phosphates Nutrition 0.000 claims description 7
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 7
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 7
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000011159 matrix material Substances 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- 230000010478 bone regeneration Effects 0.000 claims description 3
- 238000010899 nucleation Methods 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 4
- 238000007654 immersion Methods 0.000 description 24
- 229920000747 poly(lactic acid) Polymers 0.000 description 19
- 239000004626 polylactic acid Substances 0.000 description 19
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 239000007943 implant Substances 0.000 description 13
- 239000010410 layer Substances 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 239000011575 calcium Substances 0.000 description 9
- 239000011521 glass Substances 0.000 description 9
- 229910052791 calcium Inorganic materials 0.000 description 8
- 230000015556 catabolic process Effects 0.000 description 7
- 238000006731 degradation reaction Methods 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 5
- 229960001714 calcium phosphate Drugs 0.000 description 5
- 238000004113 cell culture Methods 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 239000003462 bioceramic Substances 0.000 description 3
- 210000002449 bone cell Anatomy 0.000 description 3
- 244000309464 bull Species 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 238000002149 energy-dispersive X-ray emission spectroscopy Methods 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000011859 microparticle Substances 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229920006237 degradable polymer Polymers 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000004626 scanning electron microscopy Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 238000006557 surface reaction Methods 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical group C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N Na2O Inorganic materials [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000004068 calcium phosphate ceramic Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000004821 effect on bone Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000002241 glass-ceramic Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 229920001432 poly(L-lactide) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- -1 silicate ions Chemical class 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C4/00—Compositions for glass with special properties
- C03C4/0007—Compositions for glass with special properties for biologically-compatible glass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/32—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C12/00—Powdered glass; Bead compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
- A61F2002/30677—Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Composite Materials (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Geochemistry & Mineralogy (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/439,183 US6328990B1 (en) | 1999-11-12 | 1999-11-12 | Bioactive, degradable composite for tissue engineering |
| US09/439183 | 1999-11-12 | ||
| PCT/US2000/030947 WO2001034060A1 (en) | 1999-11-12 | 2000-11-10 | Bioactive, degradable composite for tissue engineering |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU3262301A AU3262301A (en) | 2001-06-06 |
| AU774288B2 true AU774288B2 (en) | 2004-06-24 |
Family
ID=23743660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU32623/01A Ceased AU774288B2 (en) | 1999-11-12 | 2000-11-10 | Bioactive, degradable composite for tissue engineering |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6328990B1 (OSRAM) |
| EP (1) | EP1233721B1 (OSRAM) |
| JP (1) | JP2003513701A (OSRAM) |
| AT (1) | ATE290351T1 (OSRAM) |
| AU (1) | AU774288B2 (OSRAM) |
| CA (1) | CA2391232A1 (OSRAM) |
| DE (1) | DE60018600T2 (OSRAM) |
| WO (1) | WO2001034060A1 (OSRAM) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020155559A1 (en) * | 2001-01-17 | 2002-10-24 | Laurencin Cato T. | Biocompatible, biodegradable polymer-based, lighter than or light as water scaffolds for tissue engineering and methods for preparation and use thereof |
| AU2002258637A1 (en) | 2001-03-27 | 2002-10-08 | Board Of Regents The University Of Texas System | Biodegradable, electrically conductiong polymer for tissue engineering applications |
| CN1294885C (zh) * | 2001-06-05 | 2007-01-17 | 江苏阳生生物工程有限公司 | 人体骨组织生物工程支架制品及其制备方法和用途 |
| EP1408876A4 (en) | 2001-06-22 | 2004-09-22 | Durect Corp | ZERO ORDER COAXIAL IMPLANTS WITH EXTENDED RELEASE |
| US20030220692A1 (en) * | 2002-02-09 | 2003-11-27 | Shapiro Irving M. | Preparations of nucleus pulposus cells and methods for their generation, identification, and use |
| US8580291B2 (en) * | 2002-03-15 | 2013-11-12 | The Trustees Of The University Of Pennsylvania | Fibrous composite for tissue engineering |
| US8337893B2 (en) * | 2002-07-10 | 2012-12-25 | Florida Research Foundation, Inc, University Of | Sol-gel derived bioactive glass polymer composite |
| US7066962B2 (en) * | 2002-07-23 | 2006-06-27 | Porex Surgical, Inc. | Composite surgical implant made from macroporous synthetic resin and bioglass particles |
| US20060140914A1 (en) * | 2002-10-31 | 2006-06-29 | The General Hospital Corporation | Repairing or replacing tissues or organs |
| TW200507826A (en) * | 2003-02-12 | 2005-03-01 | Ceremed Inc | Random alkylene oxide copolymers for medical and surgical utilities |
| US7651682B2 (en) * | 2003-10-29 | 2010-01-26 | Gentis, Inc. | Polymerizable emulsions for tissue engineering |
| US8012210B2 (en) | 2004-01-16 | 2011-09-06 | Warsaw Orthopedic, Inc. | Implant frames for use with settable materials and related methods of use |
| CA2557231C (en) * | 2004-03-05 | 2013-12-31 | The Trustees Of Columbia University In The City Of New York | Multi-phased, biodegradable and osteointegrative composite scaffold for biological fixation of musculoskeletal soft tissue to bone |
| US7189409B2 (en) * | 2004-03-09 | 2007-03-13 | Inion Ltd. | Bone grafting material, method and implant |
| JP2006101986A (ja) * | 2004-10-01 | 2006-04-20 | Olympus Corp | 球状セラミックス粒子の製造方法、細胞の播種方法および生体組織補填体の製造方法 |
| WO2006137787A1 (en) * | 2005-06-21 | 2006-12-28 | Ge Healthcare Bio-Sciences Ab | Method for cell culture |
| US20070148251A1 (en) | 2005-12-22 | 2007-06-28 | Hossainy Syed F A | Nanoparticle releasing medical devices |
| AU2007207429A1 (en) | 2006-01-19 | 2007-07-26 | Warsaw Orthopedic, Inc. | Injectable and moldable bone substitute materials |
| EP1976459A4 (en) | 2006-01-19 | 2012-06-20 | Warsaw Orthopedic Inc | POROUS BONE IMPLANT |
| US20070249044A1 (en) * | 2006-01-30 | 2007-10-25 | University Of Illinois At Chicago | Microstructures in three dimensional gel suspensions for growth of cells |
| AU2007232187A1 (en) * | 2006-03-31 | 2007-10-11 | Csir | Bulking of soft tissue |
| US20080081362A1 (en) * | 2006-09-29 | 2008-04-03 | Daniel Keeley | Multilayered Composite for Organ Augmentation and Repair |
| US20080119927A1 (en) * | 2006-11-17 | 2008-05-22 | Medtronic Vascular, Inc. | Stent Coating Including Therapeutic Biodegradable Glass, and Method of Making |
| CN101200532B (zh) * | 2006-12-12 | 2011-04-27 | 上海杰事杰新材料股份有限公司 | 高分子量聚己内酯等可生物降解材料中空球的制备方法 |
| US8753391B2 (en) | 2007-02-12 | 2014-06-17 | The Trustees Of Columbia University In The City Of New York | Fully synthetic implantable multi-phased scaffold |
| US20100143439A1 (en) * | 2007-04-16 | 2010-06-10 | University Of Toledo | Hybrid Biomimetic Particles, Methods of Making Same and Uses Therefor |
| JP5280432B2 (ja) * | 2007-04-27 | 2013-09-04 | ヒュンジン ヤン | 比重の増加した細胞培養用支持体及びその製造方法 |
| AU2008252907A1 (en) * | 2007-05-22 | 2008-11-27 | Cinvention Ag | Partially degradable scaffolds for biomedical applications |
| DE102007031945A1 (de) * | 2007-07-06 | 2009-01-08 | Resoimplant Gmbh | Bioresorbierbares Implantat |
| EP2679672B1 (en) | 2007-07-12 | 2016-11-30 | Discgenics | Human disc tissue |
| US8591933B2 (en) * | 2007-07-18 | 2013-11-26 | The Board Of Trustees Of The University Of Illinois | Temporal release of growth factors from 3D micro rod scaffolds for tissue regeneration |
| CA2791716C (en) | 2010-03-03 | 2020-08-18 | Novabone Products, Llc | Devices and methods for the regeneration of bony defects |
| US9144629B2 (en) | 2010-03-03 | 2015-09-29 | Novabone Products, Llc | Ionically crosslinked materials and methods for production |
| WO2015147923A1 (en) | 2010-03-03 | 2015-10-01 | Novabone Products, Llc | Kit for delivering bone grafting materials |
| US10646514B2 (en) | 2013-03-14 | 2020-05-12 | Novabone Products, Llc | Processing methods of solgel-derived bioactive glass-ceramic compositions and methods of using the same |
| WO2014169249A1 (en) | 2013-04-12 | 2014-10-16 | The Trustees Of Columbia University In The City Of New York | Methods for host cell homing and dental pulp regeneration |
| US10647962B2 (en) | 2016-05-27 | 2020-05-12 | Corning Incorporated | Bioactive aluminoborate glasses |
| US10751367B2 (en) * | 2016-05-27 | 2020-08-25 | Corning Incorporated | Bioactive glass microspheres |
| US20170342383A1 (en) | 2016-05-27 | 2017-11-30 | Corning Incorporated | Lithium disilicate glass-ceramic compositions and methods thereof |
| US10676713B2 (en) | 2016-05-27 | 2020-06-09 | Corning Incorporated | Bioactive borophosphate glasses |
| FI3522944T3 (fi) * | 2016-10-05 | 2024-06-17 | Bonalive Biomaterials Oy | Luuimplantti |
| TWI794344B (zh) | 2017-11-28 | 2023-03-01 | 美商康寧公司 | 經化學強化之生物活性玻璃陶瓷 |
| EP3717030A1 (en) | 2017-11-28 | 2020-10-07 | Corning Incorporated | Bioactive glass compositions and dentin hypersensitivity remediation |
| EP3717428A1 (en) | 2017-11-28 | 2020-10-07 | Corning Incorporated | Bioactive borate glass and methods thereof |
| EP3717427A1 (en) | 2017-11-28 | 2020-10-07 | Corning Incorporated | High liquidus viscosity bioactive glass |
| CN108283729B (zh) * | 2018-01-31 | 2020-06-26 | 北京化工大学 | 具有可控镁离子释放行为的可注射骨修复材料及其制备方法 |
| CN109265942B (zh) * | 2018-08-16 | 2021-10-19 | 张海军 | 一种聚乳酸微球及其制备方法与应用 |
| CN109331223B (zh) * | 2018-09-25 | 2021-07-30 | 广州润虹医药科技股份有限公司 | 一种载药生物活性玻璃复合磷酸钙骨水泥及其应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5964807A (en) * | 1996-08-08 | 1999-10-12 | Trustees Of The University Of Pennsylvania | Compositions and methods for intervertebral disc reformation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2651320B2 (ja) * | 1992-07-16 | 1997-09-10 | 田辺製薬株式会社 | 徐放性マイクロスフェア製剤の製造方法 |
| US5626861A (en) * | 1994-04-01 | 1997-05-06 | Massachusetts Institute Of Technology | Polymeric-hydroxyapatite bone composite |
| CN1301756C (zh) * | 1995-09-14 | 2007-02-28 | 多喜兰株式会社 | 可用于骨接合术和复合植入物的材料及其制备方法 |
| US6224913B1 (en) * | 1996-05-09 | 2001-05-01 | The Trustees Of The University Of Pennsylvania | Conditioning of bioactive glass surfaces in protein containing solutions |
| JP3451417B2 (ja) * | 1996-08-12 | 2003-09-29 | タキロン株式会社 | バイオセラミックス含有セル構造体とその製造方法 |
| US5977204A (en) * | 1997-04-11 | 1999-11-02 | Osteobiologics, Inc. | Biodegradable implant material comprising bioactive ceramic |
| US5972384A (en) * | 1997-10-01 | 1999-10-26 | University Of Maryland, Baltimore | Use of biologically active glass as a drug delivery system |
-
1999
- 1999-11-12 US US09/439,183 patent/US6328990B1/en not_active Expired - Lifetime
-
2000
- 2000-11-10 AU AU32623/01A patent/AU774288B2/en not_active Ceased
- 2000-11-10 JP JP2001536070A patent/JP2003513701A/ja active Pending
- 2000-11-10 WO PCT/US2000/030947 patent/WO2001034060A1/en not_active Ceased
- 2000-11-10 AT AT00991390T patent/ATE290351T1/de not_active IP Right Cessation
- 2000-11-10 CA CA002391232A patent/CA2391232A1/en not_active Abandoned
- 2000-11-10 EP EP00991390A patent/EP1233721B1/en not_active Expired - Lifetime
- 2000-11-10 DE DE60018600T patent/DE60018600T2/de not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5964807A (en) * | 1996-08-08 | 1999-10-12 | Trustees Of The University Of Pennsylvania | Compositions and methods for intervertebral disc reformation |
Also Published As
| Publication number | Publication date |
|---|---|
| DE60018600D1 (de) | 2005-04-14 |
| AU3262301A (en) | 2001-06-06 |
| EP1233721A1 (en) | 2002-08-28 |
| US6328990B1 (en) | 2001-12-11 |
| ATE290351T1 (de) | 2005-03-15 |
| EP1233721B1 (en) | 2005-03-09 |
| JP2003513701A (ja) | 2003-04-15 |
| DE60018600T2 (de) | 2005-07-28 |
| EP1233721A4 (en) | 2003-07-23 |
| CA2391232A1 (en) | 2001-05-17 |
| WO2001034060A1 (en) | 2001-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU774288B2 (en) | Bioactive, degradable composite for tissue engineering | |
| Lee et al. | Bioactivity improvement of poly (ε-caprolactone) membrane with the addition of nanofibrous bioactive glass | |
| Qiu et al. | New bioactive, degradable composite microspheres as tissue engineering substrates | |
| Lee et al. | Membrane of hybrid chitosan–silica xerogel for guided bone regeneration | |
| Boccaccini et al. | A composites approach to tissue engineering | |
| Juhasz et al. | Bioactive ceramics: processing, structures and properties | |
| Murphy et al. | Growth of continuous bonelike mineral within porous poly (lactide‐co‐glycolide) scaffolds in vitro | |
| Shirtliff et al. | Bioactive materials for tissue engineering, regeneration and repair | |
| Leonor et al. | Growth of a bonelike apatite on chitosan microparticles after a calcium silicate treatment | |
| Hammouche et al. | Biodegradable bone regeneration synthetic scaffolds: in tissue engineering | |
| Islam et al. | Excellency of Hydroxyapatite Composite Scaffolds for Bone | |
| Oudadesse et al. | Chitosan effects on glass matrices evaluated by biomaterial. MAS-NMR and biological investigations | |
| Vijayakumar et al. | Optimization of metal ion/fuel ratio for an effective combustion of monticellite and investigation of its microbial and hemolytic activity for biomedical applications | |
| John et al. | Ceramic nanomaterials: Preparation and applications in osteoporosis and bone tissue regeneration | |
| US20050177247A1 (en) | Orthopaedic scaffolds for tissue engineering | |
| Sadat-Shojai | 1 Calcium Phosphate–Reinforced Polyester Nanocomposites for Bone Regeneration | |
| Boccaccini et al. | Biodegradable and bioactive polymer/Bioglass® composite foams for tissue engineering scaffolds | |
| Shi et al. | Yolk shell nanocomposite particles as bioactive bone fillers and growth factor carriers | |
| Bui et al. | Microspheres of chitosan-bioactive glass for application in orthopedic surgery. In vitro experiment | |
| Chen et al. | Flexible organic–inorganic hybrid bioceramic for bone tissue regeneration | |
| Allo et al. | ISSN 2079-4983 www. mdpi. com/journal/jfb | |
| Mohamed | Medical Bioceamic Materials | |
| Mutlu et al. | Bioactive Glasses/Polylactic Acid for Bone Tissue Engineering | |
| Allo | Sol-Gel Derived Biodegradable and Bioactive Organic-Inorganic Hybrid Biomaterials for Bone Tissue Engineering | |
| de Almeida Cruz et al. | Nanoceramic materials for bone regeneration: a systematic review in animal experimental studies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |